Embecta
Embecta Corp is an American medical technology company specializing in diabetes care devices and insulin delivery systems. Spun off from Becton Dickinson, the company manufactures pen needles, insulin syringes, and safety injection devices utilized for insulin administration in diabetes management. Main revenue drivers comprise global commercial sales of insulin pen needles and specialized injection consumables to retail pharmacies and healthcare distributors. Embecta serves diabetes patients, endocrinologists, primary care clinics, pharmacy chains, and medical distributors globally. The company holds a world-leading market position as the largest dedicated producer of diabetes injection devices in the medical technology industry. Headquartered in Parsippany, New Jersey, Embecta Corp is listed on the Nasdaq Stock Market.
3 of the funds FundTelligence covers report a position in Embecta.
- Legal name
- Embecta Corp
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 3
Funds holding Embecta
- Alfred Berg Global High Yield — Alfred Berg · 0.12 % (full portfolio disclosed, June 2026)
- Storebrand Global Multifactor — Storebrand · 0.01 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.0 % (partially disclosed portfolio, June 2026)